SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001193125-23-127157
Filing Date
2023-04-28
Accepted
2023-04-28 16:30:11
Documents
1
Period of Report
2022-12-31
Effectiveness Date
2023-04-28

Document Format Files

Seq Description Document Type Size
1 ARS d417506dars.pdf ARS 970598
  Complete submission text file 0001193125-23-127157.txt   1338115
Mailing Address 93 WORCESTER STREET WELLESLEY MA 02481
Business Address 570 PRESTON ST. SUITE 400 LOUISVILLE KY 40202 502-398-9250
Talaris Therapeutics, Inc. (Filer) CIK: 0001827506 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-40384 | Film No.: 23866999
SIC: 2836 Biological Products, (No Diagnostic Substances)